WeVote
Log In

Bill

Bill

HB 4051

Relating to the authority of certain healthcare providers to order and provide or dispense limited prescription drugs.

89th Legislature (2025) Introduced by James Frank

HB 4051 grants Texas healthcare providers expanded independent authority to order and dispense select prescription medications, reducing physician oversight requirements to increase medication access.

Left pending in committee
#healthcareproviders(i0387) #medicalboard #texas(v0644) #medicine&prescriptiondrugs(s7338) #packaging&labelingrequirements(s0339) #pharmacies&pharmacists(s1192) #pharmacy #texasstateboardof(v0022) #physicians(s1282)
0
WeVote Research Nonpartisan
Bill Summary · HB 4051

Legislative bill overview

HB 4051 expands the prescribing authority of certain healthcare providers—likely physician assistants, nurse practitioners, or other licensed practitioners—to order, provide, or dispense a limited set of prescription drugs without requiring a physician's signature or oversight. The bill appears designed to increase access to medications by allowing qualified non-physician providers greater autonomy in drug distribution within their scope of practice.

Why is this important

This affects healthcare accessibility and cost, particularly in underserved areas where physician shortages exist. Expanding prescribing authority can reduce wait times for routine medications and lower costs by decreasing the need for physician consultations. However, it also raises questions about patient safety oversight and standardization of care quality across different provider types.

Potential points of contention

  • Safety and liability concerns: Opponents may argue that non-physician providers lack sufficient training for independent prescribing decisions, particularly for complex drug interactions or contraindications
  • Scope creep and regulatory clarity: The phrase "limited prescription drugs" is vague—determining which drugs qualify and ensuring consistent standards across providers could create implementation challenges
  • Physician opposition: Medical organizations may resist loss of gatekeeping authority and associated revenue, arguing it undermines collaborative care models
  • Insurance and reimbursement: Unclear whether insurers will reimburse these providers equally, potentially creating access disparities

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.